{"slideshow_credits": null, "snippet": "A new proposal by the F.D.A. would simplify the process for doctors to obtain experimental drugs and greatly benefit desperately ill patients.", "abstract": "Editorial hails Food and Drug Administration's proposed simplified process for doctors to get experimental drugs for critically ill patients; holds their patients suffering life-threatening illnesses can only benefit from plan.", "section_name": "Opinion", "print_page": "28", "document_type": "article", "byline": {"person": [], "organization": "THE EDITORIAL BOARD", "original": "By THE EDITORIAL BOARD", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/02/12/opinion/quicker-access-to-experimental-drugs.html", "lead_paragraph": "A new proposal by the F.D.A. would simplify the process for doctors to obtain experimental drugs and greatly benefit desperately ill patients.", "headline": {"print_headline": "Quicker Access to Experimental Drugs", "main": "Quicker Access to Experimental Drugs", "content_kicker": "Editorial", "kicker": "Editorial"}, "_id": "54dd1af038f0d8448bfa35ba", "word_count": "602", "multimedia": [{"height": 126, "url": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 450, "url": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-articleLarge.jpg", "legacy": {"xlarge": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "450"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/02/12/opinion/12thu2WEB/12thu2WEB-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2015-02-12T00:00:00Z", "source": "The New York Times", "news_desk": "Editorial", "keywords": [{"name": "subject", "value": "Editorials", "is_major": "Y", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2"}, {"name": "organizations", "value": "Food and Drug Administration", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Doctors", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Regulation and Deregulation of Industry", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Clinical Trials", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": null, "type_of_material": "Editorial"}